Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting.

@article{Luo2018RoleOA,
  title={Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting.},
  author={Jun Luo and Gerhardt Attard and Steven P. Balk and Charlotte L Bevan and Kerry L Burnstein and Laura Cato and Artem Cherkasov and Johann S de Bono and Yan Dong and Allen C Gao and Martin E. Gleave and Hannelore V. Heemers and Mayuko Kanayama and Ralf Kittler and Joshua M. Lang and Richard W. J. Lee and Christopher J. Logothetis and Robert J. Matusik and Stephen R. Plymate and Charles L Sawyers and Luke A Selth and Howard R. Soule and Wayne D Tilley and Nancy L. Weigel and Amina Zoubeidi and Scott M Dehm and Ganesh V. Raj},
  journal={European urology},
  year={2018},
  volume={73 5},
  pages={
          715-723
        }
}
CONTEXT Although a number of studies have demonstrated the importance of constitutively active androgen receptor variants (AR-Vs) in prostate cancer, questions still remain about the precise role of AR-Vs in the progression of castration-resistant prostate cancer (CRPC). OBJECTIVE Key stakeholders and opinion leaders in prostate cancer convened on May 11, 2017 in Boston to establish the current state of the field of AR-Vs. EVIDENCE ACQUISITION The meeting "Mission Androgen Receptor Variants… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
4 Citations
60 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 60 references

Similar Papers

Loading similar papers…